Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Royalty Deals Pick Up As Alternative Financings Find Appeal

Pfizer Prices $31bn Debt Offering To Fund Seagen Buy

May 17 2023

• By Mandy Jackson

Finance Watch Public Company — • Source: Alamy

Related Content

Earlier-Stage Approvals For Tecentriq, Keytruda, Verzenio Underscore Broader Oncology Trends

Oct 15 2021

Successful Cortrophin Gel Launch Could Drive Growth At ANI For Years To Come

Mar 17 2023

Almirall Aims To Disrupt Actinic Keratosis Space With Klisyri

May 24 2021

uniQure Hemophilia B Deal With CSL Leaves M&A Fans Miffed

Jun 25 2020

Reata Lays Commercial Path For Skyclarys With First-Ever Friedreich’s Ataxia Nod

Mar 01 2023

Unity’s UBX1325 Faces Uncertain Path Forward In AMD, But DME Still Looks Promising

Mar 27 2023

Double Blow For Sangamo’s Zinc Finger Approach As Novartis And Biogen Deals Collapse

Mar 21 2023

Pfizer Pays $43bn For Seagen With Goal Of Rapidly, Globally Advancing ADCs

Mar 13 2023

Finance Watch: Summit Raises $500m For Shift From Anti-Infectives To Oncology

Mar 07 2023

CSL/UniQure’s Hemgenix To Enter Uncertain EU Market After Regulatory Nod

Feb 21 2023

Reata, Kyowa Kirin End Bardoxolone CKD Development

May 11 2023

Finance Watch: Kenvue, Acelyrin Launch Biggest Biopharma IPOs Of 2023

May 05 2023

Longer-Term DME Data Bolster Optimism Around Mechanism For Unity’s UBX1325

Apr 24 2023

Leaked Data Boost J&J and Legend’s CAR-T Carvykti But Manufacturing Issues Remain

Apr 20 2023

Finance Watch: Lucky Few Raise Cash While Many Public Biotechs Cut Costs

Apr 12 2023

Gossamer Calls It Quits On BTK Inhibitor Following Patient Deaths

Apr 04 2023

ANI Revises Its Expectations Up Following Record Revenues

May 11 2023

Finance Watch: With Limited Fundraising Options, Biotechs Restructure To Extend Cash Runways

Oct 19 2022

Novavax Hopes COVID-19/Flu Vaccine Combo Can Help It Keep Up With mRNA Leaders

Oct 10 2022

UniQure/CSL Set To Launch First Hemophilia B Gene Therapy Next Year At Record Price

Nov 23 2022

Finance Watch: New Private Funding Available Across The Spectrum For Biopharma Firms

Mar 19 2022

Akero’s Phase II Success Could Augur Brighter Days For NASH R&D

Sep 16 2022

Sobi Returns To Deal-Making With ADC Lymphoma Licensing Pact

Jul 11 2022

Pfizer And Sangamo Start Phase III Study For Hemophilia A Gene Therapy

Oct 08 2020

Related Companies

uniQure N.V.

CSL Limited

HealthCare Royalty Partners

Enanta Pharmaceuticals, Inc.

Pfizer Inc.

Seagen Inc.

Legend Biotech Corp.

Johnson & Johnson

Reata Pharmaceuticals, Inc.

Kyowa Kirin Co., Ltd.

Akero Therapeutics, Inc.

ANI Pharmaceuticals, Inc.

Athenex, Inc.

Almirall SA

Cyclerion Therapeutics, Inc.

Novavax, Inc.

BioNTech SE

Moderna, Inc.

ADC Therapeutics SA

Swedish Orphan Biovitrum AB

UNITY Biotechnology, Inc.

Gossamer Bio, Inc.

IMV Inc.

Sangamo Therapeutics, Inc.

Novartis AG

Evelo Biosciences, Inc.

Additional Topics

Financing Business Strategies Restructuring Commercial Finance Watch BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window